SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 137 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,153,615 | +396.2% | 1,387,990 | +615.2% | 0.00% | – |
| Q2 2023 | $4,061,885 | +75.9% | 194,070 | +77.5% | 0.00% | – |
| Q1 2023 | $2,308,944 | -34.3% | 109,325 | -20.8% | 0.00% | – |
| Q4 2022 | $3,514,340 | -8.1% | 138,088 | -13.3% | 0.00% | -100.0% |
| Q3 2022 | $3,826,000 | +91.0% | 159,189 | +52.9% | 0.00% | – |
| Q2 2022 | $2,003,000 | -23.5% | 104,100 | -31.0% | 0.00% | – |
| Q1 2022 | $2,620,000 | -62.9% | 150,794 | -53.2% | 0.00% | – |
| Q4 2021 | $7,054,000 | +1.3% | 322,256 | -11.6% | 0.00% | -100.0% |
| Q3 2021 | $6,966,000 | +92.9% | 364,506 | +73.3% | 0.00% | – |
| Q2 2021 | $3,612,000 | -43.5% | 210,358 | -26.5% | 0.00% | -100.0% |
| Q1 2021 | $6,396,000 | -10.4% | 286,034 | -10.9% | 0.00% | – |
| Q4 2020 | $7,136,000 | +542.3% | 320,900 | +326.2% | 0.00% | – |
| Q3 2020 | $1,111,000 | -83.6% | 75,300 | -83.5% | 0.00% | -100.0% |
| Q2 2020 | $6,754,000 | +137.1% | 455,700 | +75.5% | 0.00% | 0.0% |
| Q1 2020 | $2,848,000 | +61.9% | 259,600 | +29.6% | 0.00% | – |
| Q4 2019 | $1,759,000 | +5.6% | 200,329 | -10.1% | 0.00% | – |
| Q3 2019 | $1,665,000 | -57.3% | 222,761 | -46.8% | 0.00% | – |
| Q2 2019 | $3,903,000 | +1553.8% | 419,100 | +833.4% | 0.00% | – |
| Q1 2019 | $236,000 | -44.5% | 44,900 | -52.9% | 0.00% | – |
| Q4 2018 | $425,000 | -80.4% | 95,282 | -64.5% | 0.00% | – |
| Q3 2018 | $2,167,000 | +267.3% | 268,190 | +219.3% | 0.00% | – |
| Q2 2018 | $590,000 | -5.8% | 84,000 | +90.9% | 0.00% | – |
| Q1 2018 | $626,000 | – | 44,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |